News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
734,920 Results
Type
Article (43030)
Company Profile (275)
Press Release (691601)
Multimedia
Podcasts (87)
Webinars (20)
Section
Business (206926)
Career Advice (2057)
Deals (35866)
Drug Delivery (121)
Drug Development (81828)
Employer Resources (173)
FDA (16602)
Job Trends (15156)
News (350002)
Policy (33208)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2667)
Academic (1)
Accelerated approval (42)
Adcomms (25)
Allergies (161)
Alliances (50385)
ALS (192)
Alzheimer's disease (1755)
Antibody-drug conjugate (ADC) (366)
Approvals (16915)
Artificial intelligence (597)
Autoimmune disease (223)
Automation (51)
Bankruptcy (366)
Best Places to Work (11705)
BIOSECURE Act (20)
Biosimilars (201)
Biotechnology (177)
Bladder cancer (177)
Brain cancer (64)
Breast cancer (688)
Cancer (5329)
Cardiovascular disease (448)
Career advice (1745)
Career pathing (40)
CAR-T (299)
CDC (54)
Celiac Disease (2)
Cell therapy (799)
Cervical cancer (42)
Clinical research (70411)
Collaboration (1907)
Company closure (4)
Compensation (1270)
Complete response letters (69)
COVID-19 (2774)
CRISPR (99)
C-suite (982)
Cystic fibrosis (148)
Data (7055)
Decentralized trials (3)
Denatured (27)
Depression (153)
Dermatology (57)
Diabetes (550)
Diagnostics (7010)
Digital health (52)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (296)
Drug pricing (194)
Drug shortages (29)
Duchenne muscular dystrophy (266)
Earnings (91513)
Editorial (60)
Employer branding (21)
Employer resources (152)
Events (119157)
Executive appointments (1040)
FDA (20019)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1624)
Gene editing (213)
Generative AI (51)
Gene therapy (654)
GLP-1 (1027)
Government (4743)
Grass and pollen (6)
Guidances (396)
Healthcare (19055)
HIV (74)
Huntington's disease (52)
IgA nephropathy (91)
Immunology and inflammation (274)
Immuno-oncology (80)
Indications (157)
Infectious disease (3090)
Inflammatory bowel disease (200)
Inflation Reduction Act (14)
Influenza (129)
Intellectual property (274)
Interviews (320)
IPO (16721)
IRA (50)
Job creations (3768)
Job search strategy (1456)
JPM (59)
Kidney cancer (18)
Labor market (92)
Layoffs (557)
Leadership (35)
Legal (8069)
Liver cancer (98)
Longevity (28)
Lung cancer (716)
Lymphoma (406)
Machine learning (52)
Management (59)
Manufacturing (919)
MASH (177)
Medical device (13918)
Medtech (13995)
Mergers & acquisitions (20303)
Metabolic disorders (1411)
mRNA (176)
Multiple sclerosis (172)
NASH (18)
Neurodegenerative disease (382)
Neuropsychiatric disorders (97)
Neuroscience (3144)
Neurotech (1)
NextGen: Class of 2026 (6559)
Non-profit (4583)
Now hiring (73)
Obesity (663)
Opinion (278)
Ovarian cancer (186)
Pain (227)
Pancreatic cancer (256)
Parkinson's disease (338)
Partnered (34)
Patents (553)
Patient recruitment (587)
Peanut (61)
People (59882)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (21963)
Phase 2 (30980)
Phase 3 (23081)
Pipeline (7123)
Policy (302)
Postmarket research (2586)
Preclinical (9397)
Press Release (67)
Prostate cancer (275)
Psychedelics (49)
Radiopharmaceuticals (304)
Rare diseases (991)
Real estate (6171)
Recruiting (70)
Regulatory (25278)
Reports (54)
Research institute (2466)
Resumes & cover letters (354)
Rett syndrome (32)
RNA editing (17)
RSV (85)
Schizophrenia (164)
Series A (268)
Series B (200)
Service/supplier (11)
Sickle cell disease (106)
Special edition (22)
Spinal muscular atrophy (165)
Sponsored (48)
Startups (3670)
State (2)
Stomach cancer (18)
Supply chain (118)
Tariffs (85)
The Weekly (58)
Vaccines (1059)
Venture capital (98)
Weight loss (423)
Women's health (109)
Worklife (19)
Date
Last 7 days (636)
Last 30 days (2434)
Last 365 days (30007)
2026 (8014)
2025 (30315)
2024 (35415)
2023 (40333)
2022 (51425)
2021 (56013)
2020 (54490)
2019 (46962)
2018 (35327)
2017 (32510)
2016 (31975)
2015 (38001)
2014 (31857)
2013 (26980)
2012 (29100)
2011 (29779)
2010 (27817)
Location
Africa (755)
Alabama (90)
Alaska (7)
Arizona (334)
Arkansas (13)
Asia (40271)
Australia (6591)
California (12289)
Canada (3517)
China (1230)
Colorado (524)
Connecticut (521)
Delaware (367)
Europe (87270)
Florida (1849)
Georgia (394)
Hawaii (3)
Idaho (62)
Illinois (957)
India (80)
Indiana (560)
Iowa (22)
Japan (486)
Kansas (130)
Kentucky (45)
Louisiana (38)
Maine (73)
Maryland (1488)
Massachusetts (8787)
Michigan (346)
Minnesota (679)
Mississippi (6)
Missouri (147)
Montana (36)
Nebraska (29)
Nevada (137)
New Hampshire (83)
New Jersey (3281)
New Mexico (29)
New York (3242)
North Carolina (1573)
North Dakota (8)
Northern California (6064)
Ohio (375)
Oklahoma (22)
Oregon (41)
Pennsylvania (2486)
Puerto Rico (26)
Rhode Island (50)
South America (1141)
South Carolina (76)
South Dakota (1)
Southern California (4838)
Tennessee (199)
Texas (1933)
United States (43570)
Utah (370)
Vermont (1)
Virginia (292)
Washington D.C. (80)
Washington State (984)
West Virginia (4)
Wisconsin (119)
Wyoming (2)
734,920 Results for "kali laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunology and inflammation
Sanofi Keeps Immuno Deals Coming With Kali Bet Worth Potential $1B+
Kali Therapeutics’ T cell engager, for which Sanofi is initially paying $180 million, could potentially be developed for a range of B cell–driven autoimmune disorders.
March 23, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Kali Therapeutics Announces First Patient Dosed in Phase 1a Clinical Trial of KT501 for Rheumatoid Arthritis
March 19, 2026
·
3 min read
Press Releases
Kali Therapeutics Announces Worldwide Exclusive License Agreement with Sanofi for Next-Generation Tri-Specific T-Cell Engager for Autoimmune Diseases
March 23, 2026
·
2 min read
Press Releases
Kraig Biocraft Laboratories Increases R&D Capacity, as Project Atlas Breakthroughs Creating New Spider Silk Transgenics
March 23, 2026
·
5 min read
Press Releases
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 3, 2026
December 4, 2025
·
1 min read
Press Releases
Frontage Laboratories Completes Acquisition of Teddy Lab, Strengthening Global Central Laboratory Capabilities
March 5, 2026
·
2 min read
Press Releases
Mesa Laboratories, Inc. to Participate in Upcoming Investor Conferences - November 12, 2025
November 13, 2025
·
1 min read
Press Releases
Cambridge Isotope Laboratories, Inc. and Chemtatva Chiral Solutions Pvt. Ltd. to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad, India
October 28, 2025
·
3 min read
Press Releases
Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2025
October 5, 2025
·
1 min read
Press Releases
Cambridge Isotope Laboratories Announces Eurisotop as Direct Supplier of Environmental Standards in Europe
April 1, 2026
·
2 min read
1 of 73,492
Next
